Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists In Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials

Majed S. Al Yami, PharmD, BCPS, ASH-CHCa, Osamah M. Alfayez, PharmD, CDEb,c*, Razan Alsheikh, PharmD, BCPSb,d  "Update in Cardiovascular Safety of Glucagon Like Peptide-1 Receptor Agonists In Patients With Type 2 Diabetes. A Mixed Treatment Comparison Meta-Analysis of Randomised Controlled Trials”.  Heart, Lung and Circulation (2018)

 

Please click here to see the article.

Developed by:  EduTech / COP-ITS 2017